(Circulation. 1999;100:e39-e41.)
© 1999 American Heart Association, Inc.
Circulation Electronic Pages |
From Irvine Laboratory (A.F.L., M.B.G., A.N.N.), Regional Vascular Unit (N.J.C.), and Department of Cardiology (N.C.P., R.A.F.), Imperial College School of Medicine, St Mary's Hospital, London, UK.
Correspondence to Dr A.F. Lennox, Irvine Laboratory for Cardiovascular Investigation and Research, 10th Floor QEQM Wing, St Mary's Hospital, Praed Street, London W2 1NY, UK. E-mail a.lennox@ic.ac.uk
| Introduction |
|---|
|
Percutaneous injection of thrombin (1000 US U/mL,
GenTrac Inc) into the center of the false aneurysm cavity was
performed under duplex guidance with a 2-mL syringe and a 22-gauge
needle. After accurate placement of the needle into the
pseudoaneurysm cavity (Figures 2
and 3
), a total of 750 U (0.75 mL) was
slowly injected over 10 seconds, during which rapid thrombosis of blood
flow within the cavity occurred, as demonstrated in Figure 4
. Pulsatility from within the cavity
ceased, and the patient was discharged from hospital the following day
after repeat scanning had confirmed absence of any arterial
flow within the cavity. At subsequent review, the patient remained
asymptomatic, with a small resolving hematoma.
|
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |